Dr. Shtern is a founding member of AdMeTech’s Board of Directors, and she has served as President and CEO since December 1, 1997. The Founding Board presented Dr. Shtern with the challenge of ensuring that AdMeTech Foundation fulfill its mission – to provide unique and critically needed international leadership for expediting the development and implementation of advanced diagnostic tools for improved prevention, early detection and treatment of prostate cancer.
From January 1990 to October 2000, Dr. Shtern worked for the U.S. Department of Health and Human Services (DHHS), where she served as Chief of the Diagnostic Imaging Research Branch at the National Cancer Institute (NCI), Chair of the National Institutes of Health (NIH) – wide Diagnostic Radiology Research Committee, Director of the Federal Government-wide Technology Transfer Consortium and in other leadership positions. From March 1997 to September 1999, she served as Associate Director for Research and Technology Affairs at the U.S. Public Health Office on Women’s Health, Office of the Secretary of the DHHS, where she organized and directed the Federal Multi-Agency Consortium for Imaging and Other Technologies to Improve Women’s Health.
In these positions, she led development of a national research policy in diagnostic imaging, and created novel models for large-scale international research programs that facilitated advancement and implementation of radiologic technologies and minimally invasive diagnosis and treatment of cancer and other diseases.
At the time of her appointment to NCI in 1990, she focused on the advancement of breast cancer imaging and image guided focal treatment. She led development, standardization and implementation of the full field digital mammography, breast MRI, precisely targeted (stereotactic) needle biopsies, advanced ultrasound and other novel technologies that have transformed breast cancer care and become standard today.
Between 2000 and 2002, Dr. Shtern served as Director of Radiology Research at the Beth Israel Deaconess Medical Center, Harvard Medical School. Between November 2000 and March 2008, she was also the Director of Research at the Department of Radiology, Children’s Hospital Boston, and Harvard Medical School. In these positions, her leadership resulted in the creation of multi-disciplinary, multi-million dollar research programs dedicated to the advancement of patient care.
After receiving her M.D. from Chernovets Medical School in the former USSR and completing her residency in internal medicine at Staten Island Hospital in New York City, Dr. Shtern was appointed as a Clinical and Research Fellow at Massachusetts General Hospital and Harvard Medical School in 1984, where she was later promoted to the position of the faculty member in 1987.
Dr. Shtern has provided leadership for and participated in numerous scientific committees, advisory groups, academic workshops and conferences in the United States and throughout the world. She also has served as an expert witness in briefings and formal hearings held by US Congress, senior officials of government (including U.S. President’s Cancer Panel), industry, the media and the general public.
Articles Dr. Faina Shtern, CEO, AdMeTech Foundation has written
Why It’s Time to Raise Awareness in the Fight Against Prostate Cancer
Prostate cancer is curable when detected early, yet an American man dies from the disease every 18 minutes. Affecting one in seven men, this disease is even more common than breast cancer (which affects one in eight women), but public awareness and research funding to improve diagnosis and treatment are still lacking. That’s wh...